A mouse M-opsin monochromat: retinal cone photoreceptors have increased M-opsin expression when S-opsin is knocked out.

Center for Neuroscience, University of California, Davis, CA 95618, USA.
Vision research (Impact Factor: 2.29). 02/2011; 51(4):447-58. DOI: 10.1016/j.visres.2010.12.017
Source: PubMed

ABSTRACT Mouse cone photoreceptors, like those of most mammals including humans, express cone opsins derived from two ancient families: S-opsin (gene Opn1sw) and M-opsin (gene Opn1mw). Most C57Bl/6 mouse cones co-express both opsins, but in dorso-ventral counter-gradients, with M-opsin dominant in the dorsal retina and S-opsin in the ventral retina, and S-opsin 4-fold greater overall. We created a mouse lacking S-opsin expression by the insertion of a Neomycin selection cassette between the third and fourth exons of the Opn1sw gene (Opn1sw(Neo/Neo)). In strong contrast to published results characterizing mice lacking rhodopsin (Rho⁻/⁻) in which retinal rods undergo cell death by 2.5 months, cones of the Opn1sw(Neo/Neo) mouse remain viable for at least 1.5 yrs, even though many ventral cones do not form outer segments, as revealed by high resolution immunohistochemistry and electron microscopy. Suction pipette recordings revealed that functional ventral cones of the Opn1sw(Neo/Neo) mouse not only phototransduce light with normal kinetics, but are more sensitive to mid-wavelength light than their WT counterparts. Quantitative Western blot analysis revealed the basis of the heightened sensitivity to be increased M-opsin expression. Because S- and M-opsin transcripts must compete for the same translational machinery in cones where they are co-expressed, elimination of S-opsin mRNA in ventral Opn1sw(Neo/Neo) cones likely increases M-opsin expression by relieving competition for translational machinery, revealing an important consequence of eliminating a dominant transcript. Overall, our results reveal a striking capacity for cone photoreceptors to function with much reduced opsin expression, and to remain viable in the absence of an outer segment.

  • [Show abstract] [Hide abstract]
    ABSTRACT: Key pointsThe early receptor potential (ERP) of the mouse electroretinogram was measured in wild-type (WT) mice, in mice (Opn1sw−/−) that lack S-cone opsin and overexpress M-cone opsin, and in mice heterozygous for Rpe65.The amplitude of the ERP saturated exponentially with flash intensity. In WT mice the saturated amplitude was ∼ 1000 μV, about 20% larger than the saturated amplitude of the ERG a-wave.The ERP was 13% larger in mice overexpressing M-opsin than in WT mice, indicating that 26% of the ERP of WT mice in these experiments arises from M-opsin.After complete bleaching, the ERP of WT mice recovered in two phases, a fast phase responsible for ∼20% of the recovery having a time constant of ∼ 1 min, and a complementary slower phase with a time constant of 23 min.The fast phase of ERP recovery did not depend on the expression level of Rpe65, the retinal pigment epithelium isomerase, but the slow phase did.The fast phase of ERP recovery is concluded to arise from M-opsin regeneration, and the slow phase from the regeneration of rod plasma membrane rhodopsin.The slower phase of ERP recovery is faster than the regeneration of bulk rhodopsin in the internal disc membranes, consistent with the hypothesis that delivery of 11-cis retinal across the cytoplasmic gap between plasma and disc membranes retards regeneration of disc membrane rhodopsin.AbstractSustained vertebrate vision requires that opsin chromophores isomerized by light to the all-trans form be replaced with 11-cis retinal to regenerate the visual pigment. We have characterized the early receptor potential (ERP), a component of the electroretinogram arising from photoisomerization-induced charge displacements in plasma membrane visual pigment, and used it to measure pigment bleaching and regeneration in living mice. The mouse ERP was characterized by an outward “R2” charge displacement with a time constant of 215 μs that discharged through an apparent membrane time constant of ∼0.6 ms. After complete bleaching of rhodopsin, the ERP recovered in two phases. The initial, faster phase had a time constant of ∼ 1 min, accounted for ∼20% of the total, and was not dependent on Rpe65 expression. The slower, complementary phase had a time constant of 23 min in WT mice (C57Bl/6) and was substantially slowed in Rpe65+/−mice. Comparison of the ERPs of a mouse line expressing 150% of the normal level of cone M-opsin with those of wild type mice revealed that M-opsin contributed 26% of the total WT ERP in these experiments, with the remaining 74% arising from rhodopsin. Thus, the fast regenerating fraction (20%) corresponds approximately to the fraction of the total ERP independently estimated to arise from M-opsin. Because both phases of the ERP recover substantially faster than previous measurements of bulk rhodopsin regeneration in living mice, we conclude that delivery of the highly hydrophobic 11-cis retinal to the interior of rod photoreceptors appears to be retarded by transit across the cytoplasmic gap between plasma and disc membranes.This article is protected by copyright. All rights reserved
    The Journal of Physiology 04/2014; · 4.38 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Microglia dynamically prune synaptic contacts during development, and digest waste that accumulates in degeneration and aging. In many neurodegenerative diseases, microglial activation and phagocytosis gradually increase over months or years, with poorly defined initial triggering events. Here, we describe rapid retinal microglial activation in response to physiological light levels in a mouse model of photoreceptor degeneration that arises from defective rhodopsin deactivation and prolonged signaling. Activation, migration and proliferation of microglia proceeded along a well-defined time course apparent within 12h of light onset. Retinal imaging in vivo with optical coherence tomography (OCT) revealed dramatic increases in light-scattering from photoreceptors prior to the outer nuclear layer thinning classically used as a measure of retinal neurodegeneration. This model is valuable for mechanistic studies of microglial activation in a well-defined and optically accessible neural circuit, and for the development of novel methods for detecting early signs of pending neurodegeneration in vivo.
    Vision Research 09/2014; · 2.38 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Specific variants of human long-wavelength (L) and middle-wavelength (M) cone opsin genes have recently been associated with a variety of vision disorders caused by cone malfunction, including red-green color vision deficiency, blue cone monochromacy, myopia, and cone dystrophy. Strikingly, unlike disease-causing mutations in rhodopsin, most of the cone opsin alleles that are associated with vision disorders do not have deleterious point mutations. Instead, specific combinations of normal polymorphisms that arose by genetic recombination between the genes encoding L and M opsins appear to cause disease. Knockout/knock-in mice promise to make it possible to study how these deleterious cone opsin variants affect the structure, function, and viability of the cone photoreceptors. Ideally, we would like to evaluate different variants that cause vision disorders in humans against a control pigment that is not associated with vision disorders, and each variant should be expressed as the sole photopigment in each mouse cone, as is the case in humans. To evaluate the feasibility of this approach, we created a line of mice to serve as the control in the analysis of disease-causing mutations by replacing exon 2 through 6 of the mouse M-opsin gene with the corresponding cDNA for a human L-opsin variant that is associated with normal vision. Experiments reported here establish that the resulting pigment, which differs from the endogenous mouse M opsin at 35 amino acid positions, functions normally in mouse cones. This pigment was evaluated in mice with and without coexpression of the mouse short wavelength (S) opsin. Here, the creation and validation of two lines of genetically engineered mice that can be used to study disease-causing variants of human L/M-opsins, in vivo, are described.
    Visual Neuroscience 01/2014; 31(1):25-37. · 1.48 Impact Factor

Full-text (2 Sources)

Available from
Jun 1, 2014